Register   |   Log In Contact Us
Or login with one of the following

Log in

 

AUA 2013 - Session Highlights: Development and validation of the biopsy-based genomic prostate score (GPS) as a predictor of high grade or extracapsular prostate cancer to improve patient selection for active surveillance

SAN DIEGO, CA USA (UroToday.com) - Active surveillance (AS) is gaining momentum in this era of prostate cancer over-diagnosis and overtreatment, and many efforts are on the way to better risk-stratify patients prior to the intervention.

To continue reading this article, please Log In. If you do not have an account, please Register.